幽室及其在神经退行性疾病中的作用 - - 叙述性综述
Agata Mazurek1, Tomasz Iskra1, Agnieszka Przybyłowska2
1Department of Anatomy, Jagiellonian University Medical College, Krakow, Poland.
概括
关闭层,一个对意识至关重要的大脑结构,与帕金森氏症和阿尔茨海默氏症等神经退行性疾病有关. 它的异常与认知能力下降相关,突出显示了它在脑部疾病中的作用.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
背景情况:
- 闭层是一个皮层下灰色物质结构,具有广泛的皮层连接.
- 它在意识和突出处理中发挥作用.
- 新出现的证据表明它与神经退行性疾病有关.
研究的目的:
- 系统地审查和总结目前关于闭膜在神经退行性疾病中的作用的证据.
- 分析闭膜中的结构和连接性变化及其临床影响.
主要方法:
- 按照PRISMA 2020指南进行系统审查.
- 在谷歌学者,MEDLINE和Scopus.com上进行的搜索.
- 选了2316项研究,其中30项符合全文分析的纳入标准.
主要成果:
- 最强有力的病理证据表明,关闭参与帕金森病,勒维体痴呆症和阿尔茨海默病.
- 在前性痴呆症,中风后患者和多发性硬化症中也观察到密闭性异常.
- 关闭性改变与临床症状相关,特别是认知障碍.
结论:
- 关闭层与一系列神经退行性疾病有关.
- 作为一个关键的网络节点,它的功能障碍有助于这些疾病的病理.
- 为了理解和治疗神经退行症,需要对封闭机制进行进一步的研究.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Role of Neurotransmitters in Memory
2.4K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.4K


